Category: Client News
MJBiz Daily | Online cannabis sales boom amid COVID-19 spurs delivery-service acquisitions

The explosive growth of e-commerce during the COVID-19 pandemic has propelled new interest in acquisitions involving direct-to-consumer cannabis delivery. Some marijuana companies have acquired delivery-only cannabis dispensaries, while others have spent more to acquire vertically integrated MJ firms with home-delivery operations included.

HCP Live | Abelacimab Effective in Prevention of VTE, Including Low Bleeding Risk

Data has shown the effectiveness of factor XI in postoperative venous thromboembolism (VTE) is still unknown, particularly when compared to preoperative inhibition. A recent phase 2 study compared the efficacy and safety of abelcaimab administered postoperative in comparison to the efficacy and safety of enoxaparin in patients undergoing total knee arthroplasty.

Healio | Single abelacimab dose reduces VTE after knee replacement surgery

A single IV dose of the factor XI monoclonal antibody abelacimab appeared superior to daily enoxaparin for preventing venous thromboembolism after total knee arthroplasty, according to randomized study results. The results — presented at International Society on Thrombosis and Hemostasis Congress and published in The New England Journal of Medicine — showed abelacimab (Anthos Therapeutics) reduced blood […]